Product Information

MINOCYCLINE HCL 100 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6655 per EA under NDC 59651033950. Its NADAC has been published 263 times since Aug 11, 2021.

FDA first approved this application on May 1, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Minocycline Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MINOCYCLINE HCL 100 MG TABLET

Minocycline Hydrochloride
$0.6655per EA
High Outlier

Strength

100 mg/1

NDC

59651033950

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

MINOCYCLINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213662

FDA Approved

5/1/2020

TE Code

AB

On Market Since

5/1/2020

Pharmacological Classes

Decreased Prothrombin Activity
Tetracycline-class Drug
Tetracyclines

Price Statistics

The NADAC for MINOCYCLINE HCL 100 MG TABLET has been published 263 times since Aug 11, 2021, and over the history we have for it it has declined 64.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6655 per EA
All-time high$2.3181 (Jan 12, 2022)
All-time low$0.2732 (Nov 20, 2024)
52-week high$0.7996
52-week low$0.5918
Median price$0.7405
Average price$0.9350
Largest weekly change-58.7% (Nov 20, 2024)
Weeks tracked263
Tracking sinceAug 11, 2021

Price History

1W

+11.1%

1M

+11.1%

3M

-3.1%

6M

-16.8%

1Y

+8.7%

3Y

-14.9%

5Y

-64.3%

All

-64.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of MINOCYCLINE HCL 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE HCL 100 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.6655 per EA (NDC 59651033950), effective Aug 19, 2026.

How has the price of MINOCYCLINE HCL 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for MINOCYCLINE HCL 100 MG TABLET has declined 64.3%. It has been tracked across 263 weekly CMS publications since Aug 11, 2021.

What are the highest and lowest recorded NADAC prices for MINOCYCLINE HCL 100 MG TABLET?

Since Aug 11, 2021, the NADAC for MINOCYCLINE HCL 100 MG TABLET has ranged from a low of $0.2732 (Nov 20, 2024) to a high of $2.3181 (Jan 12, 2022), with a median of $0.7405 per EA.

Are there cheaper alternatives to MINOCYCLINE HCL 100 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MINOCYCLINE HCL 100 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MINOCYCLINE HCL 100 MG TABLET?

MINOCYCLINE HCL 100 MG TABLET (NDC 59651033950) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.